Edward Hurwitz, 10% Owner at Aegerion Pharmaceuticals, Inc. (AEGR), sold 200,733 shares at $18.67 ($3.7M) on 2012-10-16, disclosed to the SEC on 2012-10-17.
Open-market sale of $3.7M AEGR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.54 | 1,371 | $24K | 0.7% |
| 2 | $17.54 | 3,736 | $66K | 1.8% |
| 3 | $17.54 | 55,626 | $976K | 26.5% |
| 4 | $18.67 | 3,160 | $59K | 1.6% |
| 5 | $18.67 | 8,611 | $161K | 4.4% |
| 6 | $18.67 | 128,229 |
| $2.4M |
| 65.1% |
| Total | $18.33 avg | 200,733 | $3.7M | 100% |
| Filing → |
| CARA | BUY | 2014-02-05 | $1.2M | — | Filing → |
| SNSS | SELL | 2009-12-16 | $4.5M | — | Filing → |
| TPTX | SELL | 2009-09-08 | $161K | — | Filing → |